Better Science Starts with Better Questions

<p>What happens when you reach one of the most senior positions in global drug discovery — and decide the next step is to leave the security of Big Pharma behind?</p><p>In this episode of <strong>She Leads Biotech, I’m joined by Karin Conde-Knape, PhD, Chief Science Officer at Valo Health</strong>, whose international career has taken her through leadership roles at Roche, Johnson &amp; Johnson and Novo Nordisk.</p><p>We talk about why Karin believes better drug discovery needs to <strong>start with human data</strong>, how asking the right questions earlier can prevent years of time and investment being committed to the wrong path, and where data, experience and intuition belong in scientific decision-making.</p><p>We also explore Karin’s decision to move from Big Pharma to biotech — what she describes as an <strong>“easier choice, not a comfortable choice”</strong> — and why impact, people and purpose became increasingly important at this stage of her career.</p><p>Our conversation moves beyond the science into leadership: creating psychological safety, challenging the <strong>thought process rather than the individual</strong>, developing resilient future leaders, embracing AI and new technologies, and building teams that genuinely want to follow you.</p><p>A fascinating conversation about <strong>drug discovery, human data, innovation, career courage and the leadership required to turn better questions into better science.</strong></p><p></p>